Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: For human use
Package code: 1062009
Name of medicinal product: ADVANTAN
Active substances:
Methylprednisolone aceponate
Estonian, English, Latin
ATC code: D07AC14
Dosage form: ointment
Route of administration: cutaneous use
Strengh: 1mg 1g
Amount in package: 15g 1TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: Symptomatic treatment of dermatitis and eczema (incl. atopic dermatitis and eczema in children).
Safety features: Yes
Summary of product characteristics (SPC):  (last updated January 3, 2020)
Package information leaflet (PIL): EST  (last updated March 24, 2022)
Labelling:  (last updated January 3, 2020)
Last imported to Estonia: August 31, 2022
Marketing authorization holder: LEO Pharma A/S 
Marketing authorization number: 171797 
Marketing authorization issued on: May 9, 1997 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: National 
Percent Valid from Valid until Valid Diagnosis Doctor's speciality Primary Age Other
50  01.10.2022     Yes      No      
75  01.10.2022     Yes  L20-L20; L40-L40; L23-L23    No      
90  01.10.2022     Yes  L20-L20; L40-L40; L23-L23    No      
90  01.10.2022     Yes  L20-L20; L40-L40; L23-L23    No      
90  01.10.2022     Yes  L20-L20; L40-L40; L23-L23    No  4 years - 17 years   
90  01.10.2022     Yes  L20-L20; L40-L40; L23-L23    No  from 63 years   
100  01.10.2022     Yes  L20-L20; L40-L40; L23-L23    No  until 4 years   
100  01.10.2022     Yes      No  until 4 years   
Reference price:   
Under reference price:   
Reference price of daily dose:   
Entry/Changing date: September 6, 2022
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere